Consistently, siRNA-mediated targeting of GREM1 in mesenchymal-like colon cancer cells (e.g. SW620) led to the suppression of cell growth and angiogenesis (Liu et al. 2019). The gene discussed is GREM1; the disease is malignant colon neoplasm.